An Effectiveness & Safety Study of PF-04383119 for the Treatment of Pain

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02868775` - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome	N/A
Completed	`NCT00672087` - Diagnostic Challenges in IC (and Male CPPS)
Completed	`NCT01482676` - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction	N/A
Terminated	`NCT00380783` - Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis	Phase 2
Completed	`NCT00775281` - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.	N/A
Completed	`NCT05260112` - Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide	N/A
Completed	`NCT05752344` - Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era
Completed	`NCT01613586` - A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)	Phase 2
Completed	`NCT02411110` - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome	Phase 2
Recruiting	`NCT06299683` - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment	N/A
Completed	`NCT00248664` - Events Preceding Interstitial Cystitis (EPIC)	N/A
Completed	`NCT02214550` - Chronic Pain Risk Associated With Menstrual Period Pain	Phase 4
Completed	`NCT04275297` - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome	N/A
Terminated	`NCT00999518` - A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome	Phase 2
Completed	`NCT00675298` - Linkage Analysis in Interstitial Cystitis	N/A
Terminated	`NCT02781103` - Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain	N/A
Recruiting	`NCT01074567` - DMSO Efficacy in IC/PBS Patients During and After Treatment	N/A
Completed	`NCT02497976` - Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis	Phase 3
Terminated	`NCT02787083` - A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis	Phase 3
Withdrawn	`NCT00275379` - Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis	N/A

NCT number	NCT00601484
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 2
Start date	March 17, 2008
Completion date	April 15, 2009

An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms